Grace Therapeutics Inc GRCE

$1.85 +0.07 (3.93%)

Valuation

Market cap
38,075,000
Revenue TTM
$0
Net income TTM
$-7,790,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
77,103
Avg volume
130,930
Day's range
$1.79 – $1.90
Shares out
21,036,000
Stochastic %K
29%
Beta
0.43
Analysts
Moderate Buy
Price target
$6.00

Price

Company profile

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a...

Show more

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a topical bio adhesive film-forming bupivacaine spray for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.

Industry
Biotechnology
Sector
Healthcare
Phone
609 322 1602
Website
https://www.gracetx.com
Address
103 Carnegie Center, Suite 300, Princeton, United States

Latest news

Stocktwits

focafoca99 Nov 5, 1:24 PM
$GRCE attend BIO-Europe 2026 in Cologne and the Craig-Hallum Alpha Select conference in New York this November. https://www.rapidticker.com/news/grce-grace-therapeutics-announces-participation-in-cfd423
0 replies
CharlieeMungerTWITS Nov 4, 11:56 PM
$RYTM I LOVE BIOOOOOOO! $CELC $GRCE stay tuned !
1 replies
ReelHeel98 Nov 3, 5:23 PM
$GRCE opens up 10% and then drops back down. It is time for this thing to run back up. 
0 replies
SergioCdot Oct 29, 12:35 PM
$GRCE I’ve got questions, and I’m hoping we get some decent answers soon
1 replies
deweyeggbert Oct 28, 9:57 PM
$GRCE this is getting interesting. Small volume, small float, high price volitility, and a pretty successful bio fund keeps buying. Maybe a buyout is in the cards. We'll see...
0 replies
deweyeggbert Oct 28, 4:19 PM
$GRCE what does opaleye see that others are missing? They keep accumulating shares in small increments, which are adding up to a sizable position.
1 replies
Stockseeking Oct 27, 3:59 PM
$GRCE Bought more, soon >2
0 replies
HarveySpecter20 Oct 26, 10:50 PM
$GRCE and they did it again. https://ir.stockpr.com/gracetx/sec-filings-email/content/0001493152-26-048591/ownership.html
1 replies